|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1992-1-17
|
|
pubmed:abstractText |
Ora; ciprofloxacin was studied as a prophylactic antimicrobial agent in high- and low-risk patients undergoing endoscopic retrograde cholangiography. Ciprofloxacin appeared to be effective, good serum levels were attained, and the drug compared favourably on grounds of cost and convenience with a parenterally-administered cephalosporin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0195-6701
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19 Suppl C
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
65-70
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1684197-Administration, Oral,
pubmed-meshheading:1684197-Cefazolin,
pubmed-meshheading:1684197-Cholangiopancreatography, Endoscopic Retrograde,
pubmed-meshheading:1684197-Ciprofloxacin,
pubmed-meshheading:1684197-Double-Blind Method,
pubmed-meshheading:1684197-Female,
pubmed-meshheading:1684197-Humans,
pubmed-meshheading:1684197-Male,
pubmed-meshheading:1684197-Middle Aged,
pubmed-meshheading:1684197-Risk Factors,
pubmed-meshheading:1684197-Sepsis
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Prevention of sepsis following endoscopic retrograde cholangiopancreatography.
|
|
pubmed:affiliation |
Department of Medicine II, University of Southampton.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
